Profit Margin (Quarterly) Chart

Historical Profit Margin (Quarterly) Data

View and export this data back to 2009. Start Trial.
Date Value
June 30, 2026 -40.87%
March 31, 2026 -14.79%
December 31, 2025 0.18%
September 30, 2025 3.93%
June 30, 2025 10.03%
March 31, 2025 0.18%
December 31, 2024 -10.04%
September 30, 2024 -17.98%
June 30, 2024 -12.89%
March 31, 2024 -15.79%
December 31, 2023 -15.31%
September 30, 2023 36.90%
June 30, 2023 -10.82%
March 31, 2023 -11.58%
December 31, 2022 -14.47%
September 30, 2022 -16.27%
June 30, 2022 -11.19%
March 31, 2022 -17.08%
December 31, 2021 -16.34%
September 30, 2021 -13.09%
June 30, 2021 -4.89%
March 31, 2021 -0.23%
December 31, 2020 -5.04%
September 30, 2020 -9.70%
June 30, 2020 -23.40%
Date Value
March 31, 2020 -16.87%
December 31, 2019 -9.46%
September 30, 2019 -11.95%
June 30, 2019 -12.70%
March 31, 2019 -16.73%
December 31, 2018 -310.4%
September 30, 2018 -18.26%
June 30, 2018 -26.69%
March 31, 2018 -29.29%
December 31, 2017 -147.0%
September 30, 2017 -43.02%
June 30, 2017 -45.28%
March 31, 2017 -26.20%
December 31, 2016 -18.54%
September 30, 2016 -21.21%
June 30, 2016 -20.79%
March 31, 2016 -26.68%
December 31, 2015 52.04%
September 30, 2015 -37.81%
June 30, 2015 -29.27%
March 31, 2015 -43.95%
December 31, 2014 -36.36%
September 30, 2014 -13.79%
June 30, 2014 -21.39%
March 31, 2014 -46.45%

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Range, Past 5 Years

View Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Profit Margin (Quarterly) Benchmarks

View Profit Margin (Quarterly) Benchmarks
Start Trial
Enovis Corp. -0.18%
Edwards Lifesciences Corp. 13.87%
Intuitive Surgical, Inc. 17.20%
Kewaunee Scientific Corp. 2.78%
STAAR Surgical Co. 8.62%